Tolerability of mycophenolate sodium in renal transplant recipients.

Background Kidney transplant recipients (KTR) receive fixed daily doses of mycophenolate sodium as part of the immunosuppressive regimen. Dose reductions occur primarily due to adverse events and may be associated with an increased risk of acute rejection and graft loss. Objectives To evaluate the tolerability of mycophenolate in kidney transplant recipients receiving tacrolimus and prednisone.

The influence of clinical, environmental, and socioeconomic factors on five-year patient survival after kidney transplantation.

Introduction: The risk of death after kidney transplant is associated with the age of the recipient, presence of comorbidities, socioeconomic status, local environmental characteristics and access to health care.

Objective: To investigate the causes and risk factors associated with death during the first 5 years after kidney transplantation.

Methods: This was a single-center, retrospective, matched case-control study.